AstraZeneca Restores Supply Of Key Recalled Products In India; Plans To Outsource Manufacturing And Launch More Drugs
This article was originally published in PharmAsia News
Executive Summary
After being battered by a government probe and voluntary recalls earlier this year, the company appears to be gearing up for a stronger presence in India.